Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ARVN stock hub

Arvinas, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ARVNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

652.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ARVN

In the news

Latest news · ARVN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-16.2

P25 -106.6P50 -46.9P75 -3.1

ROIC-14.2

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ARVN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001655759
Company name	Arvinas, Inc.
Country	United States
Country code	US
Cusip	04335A105
Employees	246
Employees Change	-184%
Employees Change Percent	-42.79
Enterprise value	$-24.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2018-09-27
Isin	US04335A1051
Last refreshed	2026-05-10
Market cap	$652.3M
Market cap category	Small-Cap
Price	$10.11
Price currency	USD
Rev Per Employee	1,067,479.67x
Sector	Healthcare
Sic	2834
Symbol	ARVN
Website	https://www.arvinas.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.39%
FCF yield	-42.27%
P/B ratio	1.48x
P/S ratio	2.48x
PS Forward	6.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-43.75%
EBITDA Margin	-42.61%
Gross margin	100%
Gross Profit	$262.6M
Gross Profit Growth	-0.3%
Gross Profit Growth Q	-83.95%
Gross Profit Growth3 Y	25.96%
Gross Profit Growth5 Y	58.93%
Net Income	$-80.8M
Net Income Growth Years	2%
Pretax Margin	-30.65%
Profit Margin	-30.77%
Profit Per Employee	$-328,455
ROA	-7.94
Roa5y	-12.46
ROCE	-19.97
ROE	-16.23
Roe5y	-35.51
ROIC	-14.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	51.62%
Cagr3y	-26.34%
Cagr5y	-30.79%
EPS Growth Years	2
Revenue Growth	-0.3x
Revenue Growth Q	-83.95x
Revenue Growth Years	0x
Revenue Growth3 Y	25.96x
Revenue Growth5 Y	58.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.29
Assets	$717.9M
Cash	$685.4M
Current Assets	$700.7M
Current Liabilities	$142.5M
Debt	$8.9M
Debt Equity	$0.02
Equity	$433.9M
Liabilities	$284M
Long Term Assets	$17.2M
Long Term Liabilities	$141.5M
Net Cash	$676.5M
Net Cash By Market Cap	$104
Net Cash Growth	-34.3%
Net Debt Equity	$-1.56
Tangible Book Value	$433.9M
Tangible Book Value Per Share	$6.83
WACC	13.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.92
Net Working Capital	$-125.5M
Quick ratio	4.85
Working Capital	$558.2M
Working Capital Turnover	$0.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.39%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	51.57%
200-day SMA	10.52
3Y total return	-60.04%
50-day SMA	11.3
50-day SMA vs 200-day SMA	50over200
5Y total return	-84.11%
All Time High	108.5
All Time High Change	-90.68%
All Time High Date	2021-07-29
All Time Low	5.9
All Time Low Change	71.36%
All Time Low Date	2025-05-15
ATR	0.6
Beta	1.8
Beta1y	0.9
Beta2y	1.23
Ch YTD	-14.76
High	10.3
High52	14.51
High52 Date	2026-03-10
High52ch	-30.32%
Low	9.97
Low52	5.9
Low52 Date	2025-05-15
Low52ch	71.36%
Ma50ch	-10.55%
Premarket Change Percent	0.79
Premarket Price	$10.27
Premarket Volume	6,764
Price vs 200-day SMA	-3.88%
RSI	40.65
RSI Monthly	38.95
RSI Weekly	43.06
Sharpe ratio	0.95x
Sortino ratio	1.53
Total Return	1.39%
Tr YTD	-14.76
Tr1m	-11.08%
Tr1w	-3.81%
Tr3m	-25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	5
Analyst Price Target Top	$14.8
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.96
Earnings Revenue Estimate	16,432,640x
Earnings Revenue Estimate Growth	-91.3x
Operating Income	$-114.9M
Operating margin	-43.75
Price target	$15.57
Price Target Change	$54.01
Price Target Change Top	$46.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55,891,394%
Float Percent	86.63%
Net Borrowing	-200,000
Shares Insiders	2.25%
Shares Institutions	79.46%
Shares Out	64,517,472
Shares Qo Q	-11.34%
Shares Yo Y	-1.39%
Short Float	7.85%
Short Ratio	4.61
Short Shares	6.8

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-319.7M
Average Volume	785,704.05x
Bv Per Share	6.83
CAPEX	$-1.9M
Ch1m	-11.08
Ch1w	-3.81
Ch1y	51.57
Ch3m	-25
Ch3y	-60.04
Ch5y	-84.11
Ch6m	-4.89
Change	-0.79%
Change From Open	-0.1
Close	10.19
Days Gap	-0.69
Depreciation Amortization	3,000,000
Dollar Volume	6,018,159.5
Earnings Date	2026-05-12
Earnings Time	bmo
EBIT	$-114.9M
EBITDA	$-111.9M
EPS	$-1.14
F Score	3
FCF	$-275.7M
FCF EV Yield	1,137.92x
FCF Per Share	$-4.27
Financing CF	-91,400,000
Fiscal Year End	December
Founded	2,015
Income Tax	$300,000
Investing CF	407,600,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-24
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Ma150	11.49
Ma150ch	-12.03%
Ma20	10.51
Ma20ch	-3.79%
Net CF	42,400,000
Next Earnings Date	2026-05-12
Open	10.12
Optionable	Yes
Position In Range	42.42
Post Close	10.11
Postmarket Change Percent	-3.64
Postmarket Price	$9.74
Ppne	13,400,000
Pre Close	10.19
Price Date	2026-05-08
Ptbv Ratio	1.5
Relative Volume	0.76x
Revenue	262,600,000x
SBC By Revenue	16.76x
Share Based Comp	44,000,000
Tax By Revenue	0.11x
Tr6m	-4.89%
Us State	Connecticut
Volume	595,268
Z Score	-0.85

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ARVN pay a dividend?

Capital-return profile for this ticker.

Performance

ARVN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ARVN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+79.5%

Float: +86.6% of shares outstanding

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ARVN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.7

Neutral momentum band

Price vs 200-day MA

-3.9%

50/200-day relationship not available

Beta (5Y)

1.80

More volatile than the market

Sharpe ratio

0.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ARVN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ARVN stock rating?

Arvinas, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ARVN analysis?

The full report lives at /stocks/ARVN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ARVN?

The latest report frames ARVN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ARVN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.